Jessica Sachs
Chief Tech/Sci/R&D Officer at COGENT BIOSCIENCES, INC.
Net worth: 8 709 $ as of 2024-03-30
Profile
Jessica Sachs is currently the Chief Medical Officer at Cogent Biosciences, Inc. She previously worked as an Associate Director at Genzyme Corp.
from 2010 to 2012 and as a Senior Medical Director-Clinical Research at Takeda Pharmaceutical Co., Ltd.
from 2012 to 2017.
Dr. Sachs holds a doctorate degree from Washington University in St. Louis and an undergraduate degree from Duke University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC.
0.00% | 2024-02-21 | 1,296 ( 0.00% ) | 8 709 $ | 2024-03-30 |
Jessica Sachs active positions
| Companies | Position | Start |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2019-05-31 |
Former positions of Jessica Sachs
| Companies | Position | End |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 2017-03-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2011-12-31 |
Training of Jessica Sachs
| Washington University in St. Louis | Doctorate Degree |
| Duke University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jessica Sachs
